{"id":"https://openalex.org/W25120433","doi":null,"title":"Nefiracetam. Daiichi Seiyaku.","display_name":"Nefiracetam. Daiichi Seiyaku.","publication_year":2002,"publication_date":"2002-05-01","ids":{"openalex":"https://openalex.org/W25120433","mag":"25120433","pmid":"https://pubmed.ncbi.nlm.nih.gov/12090554"},"language":"en","primary_location":{"id":"pmid:12090554","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12090554","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087626408","display_name":"Francesco Crespi","orcid":"https://orcid.org/0000-0001-7657-7824","observed_orcids":["https://orcid.org/0000-0001-7657-7824"]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Francesco Crespi","raw_affiliation_strings":["GlaxoWellcome SpA, Pharmacology Dept, Verona, Italy. fc20377@GlaxoWellcome.co.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoWellcome SpA, Pharmacology Dept, Verona, Italy. fc20377@GlaxoWellcome.co.uk","institution_ids":["https://openalex.org/I4210128413"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5087626408"],"corresponding_institution_ids":["https://openalex.org/I4210128413"],"apc_list":null,"apc_paid":null,"fwci":0.2064,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.53854086,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"3","issue":"5","first_page":"788","last_page":"93"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.8852999806404114,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.8852999806404114,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.05900000035762787,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.011500000022351742,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nefiracetam","display_name":"nefiracetam","score":0.9990000128746033},{"id":"https://openalex.org/keywords/post-stroke-sequelae","display_name":"stroke sequelae","score":0.8579999804496765},{"id":"https://openalex.org/keywords/post-stroke-cognitive-impairment","display_name":"post-stroke cognitive impairment","score":0.7300000190734863},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8629999756813049},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.6169999837875366},{"id":"https://openalex.org/keywords/new-drug-application","display_name":"new drug applications","score":0.5299999713897705},{"id":"https://openalex.org/keywords/drug-sales-forecasting","display_name":"drug sales forecasting","score":0.574999988079071},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.36899998784065247}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7056424021720886},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6092528700828552},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2151637077331543}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002491","descriptor_name":"Central Nervous System Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002491","descriptor_name":"Central Nervous System Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002491","descriptor_name":"Central Nervous System Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002491","descriptor_name":"Central Nervous System Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002561","descriptor_name":"Cerebrovascular Disorders","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003704","descriptor_name":"Dementia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003704","descriptor_name":"Dementia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011760","descriptor_name":"Pyrrolidinones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011760","descriptor_name":"Pyrrolidinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011760","descriptor_name":"Pyrrolidinones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12090554","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12090554","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},{"id":"mag:25120433","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12090554","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":132,"referenced_works":["https://openalex.org/W2080287250","https://openalex.org/W1877319790","https://openalex.org/W2000054304","https://openalex.org/W1968608231","https://openalex.org/W2033814322","https://openalex.org/W2081880339","https://openalex.org/W2038561863","https://openalex.org/W2034651748","https://openalex.org/W2054091111","https://openalex.org/W2138997487","https://openalex.org/W2099478180","https://openalex.org/W2085408699","https://openalex.org/W2172011313","https://openalex.org/W2043525076","https://openalex.org/W2035598121","https://openalex.org/W2043162533","https://openalex.org/W1980805930","https://openalex.org/W2094359469","https://openalex.org/W1494010743","https://openalex.org/W2006053579","https://openalex.org/W2150708910","https://openalex.org/W2133683434","https://openalex.org/W2019931248","https://openalex.org/W2000130976","https://openalex.org/W2062463079","https://openalex.org/W1984991691","https://openalex.org/W2136191649","https://openalex.org/W2013080889","https://openalex.org/W2057924235","https://openalex.org/W2118438688","https://openalex.org/W1997765371","https://openalex.org/W2159241623","https://openalex.org/W1989029077","https://openalex.org/W2112137180","https://openalex.org/W2074967116","https://openalex.org/W2071250933","https://openalex.org/W2007860569","https://openalex.org/W1599319686","https://openalex.org/W1566518481","https://openalex.org/W2145664048","https://openalex.org/W1749057191","https://openalex.org/W1500569882","https://openalex.org/W2079864604","https://openalex.org/W2133560125","https://openalex.org/W4248307879","https://openalex.org/W1990929336","https://openalex.org/W2085488786","https://openalex.org/W2036319351","https://openalex.org/W2056649843","https://openalex.org/W4246912672","https://openalex.org/W2083819018","https://openalex.org/W2010492400","https://openalex.org/W2002600603","https://openalex.org/W1968418618","https://openalex.org/W2162775240","https://openalex.org/W1995658722","https://openalex.org/W2021890154","https://openalex.org/W1984938584","https://openalex.org/W1999513543","https://openalex.org/W1976482700","https://openalex.org/W1556161696","https://openalex.org/W2043364106","https://openalex.org/W2028511100","https://openalex.org/W1480513449","https://openalex.org/W2064474429","https://openalex.org/W1988595550","https://openalex.org/W2049676741","https://openalex.org/W2017361992","https://openalex.org/W2099820941","https://openalex.org/W1982728552","https://openalex.org/W1994898191","https://openalex.org/W2010157600","https://openalex.org/W1984189293","https://openalex.org/W2065117619","https://openalex.org/W2138170649","https://openalex.org/W2042728043","https://openalex.org/W1982177213","https://openalex.org/W2109637158","https://openalex.org/W2100971636","https://openalex.org/W1492127714","https://openalex.org/W1979037838","https://openalex.org/W2141152871","https://openalex.org/W2081119737","https://openalex.org/W2147817553","https://openalex.org/W2105245235","https://openalex.org/W2068841959","https://openalex.org/W1993780110","https://openalex.org/W1967983600","https://openalex.org/W2029965714","https://openalex.org/W1991063399","https://openalex.org/W1966934847","https://openalex.org/W1976962789","https://openalex.org/W1978538275","https://openalex.org/W2119972841","https://openalex.org/W2132350422","https://openalex.org/W2089201761","https://openalex.org/W2002780348","https://openalex.org/W2116368971","https://openalex.org/W1965427013","https://openalex.org/W2163637000","https://openalex.org/W1979614243","https://openalex.org/W2171414013","https://openalex.org/W2073032316","https://openalex.org/W1510757466","https://openalex.org/W2007372862","https://openalex.org/W2092726215","https://openalex.org/W2001465365","https://openalex.org/W2062477559","https://openalex.org/W70522370","https://openalex.org/W2396331417","https://openalex.org/W1827142872","https://openalex.org/W2090023121","https://openalex.org/W1970264142","https://openalex.org/W2121710921","https://openalex.org/W2154391980","https://openalex.org/W2037174026","https://openalex.org/W2053989438","https://openalex.org/W2067008379","https://openalex.org/W2090518754","https://openalex.org/W2159141169","https://openalex.org/W2022347217","https://openalex.org/W2147672557","https://openalex.org/W1993938009","https://openalex.org/W1908661569","https://openalex.org/W2170592109","https://openalex.org/W2144829212","https://openalex.org/W2099865289","https://openalex.org/W2096167103","https://openalex.org/W2157209018","https://openalex.org/W2129889192","https://openalex.org/W2050643127","https://openalex.org/W2128988164"],"related_works":["https://openalex.org/W3188460962","https://openalex.org/W4234028630","https://openalex.org/W2036937038","https://openalex.org/W572445371","https://openalex.org/W2272158061","https://openalex.org/W2338041218","https://openalex.org/W2416881765","https://openalex.org/W2015196132","https://openalex.org/W618972877","https://openalex.org/W2036671134"],"abstract_inverted_index":{"Nefiracetam":[0],"(DM-9384)":[1],"is":[2],"a":[3,69],"cerebral":[4,106],"metabolic":[5],"product":[6],"under":[7],"development":[8],"by":[9,122],"Daiichi":[10,131],"for":[11,33,60,87,94,157],"the":[12,16,31,34,67,78,95,111,119,123,141],"potential":[13],"treatment":[14,35],"of":[15,18,36,42,77,89,105,113,118,125,177,193],"after-effects":[17],"cerebrovascular":[19],"disorders.":[20],"By":[21,48],"September":[22],"1999,":[23,115],"nefiracetam":[24,153],"was":[25,108],"In":[26,64,144],"phase":[27,74,98],"II":[28],"trials":[29,52,76],"in":[30,53,58,71,83,85,101,128,140,159,161,168,175,181,188],"US":[32],"mental":[37],"symptoms":[38],"associated":[39],"with":[40,103,116,163],"sequelae":[41,104],"stroke":[43],"and":[44,190],"Alzheimer's":[45],"type":[46],"dementia.":[47],"August":[49],"2000,":[50,66],"clinical":[51],"China":[54],"had":[55],"been":[56],"completed":[57],"preparation":[59,86],"an":[61,90],"NDA":[62,135],"filing":[63],"November":[65],"companypredicted":[68],"launch":[70],"2002.":[72],"Modified":[73],"III":[75,99],"compound":[79],"were":[80],"being":[81],"repeated":[82],"Japan":[84,160,176],"re-filing":[88],"NDA.":[91],"The":[92],"protocol":[93],"initial":[96],"Japanese":[97,134],"retrial":[100],"patients":[102],"infarction":[107],"approved":[109],"at":[110,148],"end":[112,124],"July":[114],"completion":[117],"trial":[120],"expected":[121],"2000.":[126],"However,":[127],"February":[129],"2002":[130,170],"withdrew":[132],"its":[133,164],"due":[136],"to":[137,184,196],"insufficient":[138],"efficacy":[139],"revised":[142],"trial.":[143],"December":[145],"2001,":[146],"analysts":[147],"Morgan":[149],"Stanley":[150],"predicted":[151],"that":[152],"would":[154],"be":[155],"submitted":[156],"approval":[158],"2002,":[162,182],"approval/launch":[165],"taking":[166],"place":[167],"late":[169],"or":[171],"2003.":[172],"Estimated":[173],"sales":[174,192],"yen":[178,185,194],"3":[179],"billon":[180],"rising":[183],"13":[186],"billion":[187,198],"2005":[189],"peak":[191],"20":[195],"30":[197],"are":[199],"predicted.":[200]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}